American Oncology Network Inc. (AONC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, American Oncology Network Inc. (AONC) has a cash flow conversion efficiency ratio of 0.110x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($11.93 Million) by net assets ($108.01 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check American Oncology Network Inc. (AONC) strategic asset index to assess the company's strategic physical and investment asset allocation.
American Oncology Network Inc. - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how American Oncology Network Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. See American Oncology Network Inc. net assets for net asset value and shareholders' equity analysis.
American Oncology Network Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of American Oncology Network Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Coltene Holding AG
SW:CLTN
|
0.018x |
|
Crescent Biopharma, Inc.
NASDAQ:CBIO
|
N/A |
|
Zhihu Inc ADR
NYSE:ZH
|
0.012x |
|
Nanning Baling Technology
SHE:002592
|
-0.008x |
|
Elma Electronic AG
SW:ELMN
|
-0.001x |
|
Ramco Industries Limited
NSE:RAMCOIND
|
0.023x |
|
Mount Gibson Iron Ltd
AU:MGX
|
0.026x |
|
Iron Horse Acquisitions II Corp. Common Stock
NASDAQ:IRHO
|
-0.002x |
Annual Cash Flow Conversion Efficiency for American Oncology Network Inc. (2020–2024)
The table below shows the annual cash flow conversion efficiency of American Oncology Network Inc. from 2020 to 2024. For the full company profile with market capitalisation and key ratios, see AONC stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $108.01 Million | $-4.94 Million | -0.046x | +82.14% |
| 2023-12-31 | $70.71 Million | $-18.12 Million | -0.256x | -134.22% |
| 2022-12-31 | $62.02 Million | $-6.78 Million | -0.109x | -1909.83% |
| 2021-12-31 | $226.04 Million | $-1.23 Million | -0.005x | -100.00% |
| 2020-12-31 | $24.17K | $37.24 Million | 1541.215x | -- |
About American Oncology Network Inc.
American Oncology Network, Inc., through its subsidiaries, provides oncology management services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with pathology reports; in-house specialty pharmacy services with patient education, financial assistance, … Read more